Thomas W. Patapoff
Thomas W. Patapoff publishes mostly in Molecular Biology, Radiology, Nuclear Medicine and Imaging and Materials Chemistry, on topics such as Protein purification and stability, Monoclonal and Polyclonal Antibodies Research and Viral Infectious Diseases and Gene Expression in Insects.
- World rank
- #734,106 of 7,710,434 ranked researchers
- Rank in United States
- #247,110 of 1,627,098
- Works
- 68
- Citations
- 3.7k
- Citations per work
- 54.8
What does Thomas W. Patapoff research?
Thomas W. Patapoff's work is mostly in Biochemistry, Genetics and Molecular Biology (36%), Medicine (12%), Chemistry (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2537.4%
- Life Sciences2536.4%
- Physical Sciences1014.4%
- Chemistry46.2%
- Materials Science35.1%
- Engineering23.1%
- Health Sciences811.8%
- Medicine811.8%
- 1Molecular Biology36% of their works
- 2Radiology, Nuclear Medicine and Imaging12% of their works
- 3Materials Chemistry5% of their works
- 4Organic Chemistry4% of their works
- 5Biomedical Engineering3% of their works
- 6Spectroscopy2% of their works
Research topics
- Protein purification and stability
- Monoclonal and Polyclonal Antibodies Research
- Viral Infectious Diseases and Gene Expression in Insects
- Glycosylation and Glycoproteins Research
- Protein Structure and Dynamics
- Enzyme Structure and Function
- Protein Interaction Studies and Fluorescence Analysis
- Advanced Glycation End Products research
Which keywords describe Thomas W. Patapoff's research?
The keywords of their largest research topics: Monoclonal Antibodies, Therapeutic Antibodies, Glycosylation, Biopharmaceuticals, Protein Aggregation, Antibody Engineering, Fc Receptors and Mammalian Cells.
- Advanced Glycation End Products
- Protein Binding
- Macromolecular Crystallography
- Protein
- Cancer
- Mammalian Cells
- Antibody Engineering
- Biopharmaceuticals
- Therapeutic Antibodies
- Monoclonal Antibodies
- Glycosylation
- Protein Aggregation
- Fc Receptors
- Recombinant Protein
- Glycans
- Structure
- Structure Solution
- Serum Albumin
- HMGB1
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Monoclonal Antibodies582 topics
- Therapeutic Antibodies582 topics
- Glycosylation433 topics
- Biopharmaceuticals351 topic
- Protein Aggregation351 topic
- Antibody Engineering231 topic
- Fc Receptors231 topic
- Mammalian Cells111 topic
- Recombinant Protein111 topic
- Cancer91 topic
- Glycans91 topic
- Protein71 topic
- Structure71 topic
- Macromolecular Crystallography61 topic
- Structure Solution61 topic
- Protein Binding41 topic
- Serum Albumin41 topic
- Advanced Glycation End Products31 topic
- HMGB131 topic
Where does Thomas W. Patapoff work?
Thomas W. Patapoff's main affiliation in the publication record is Pharmaceutical Product Development (United States), United States.
How many publications and citations does Thomas W. Patapoff have?
OpenAlex counts 68 works and 3,729 citations for Thomas W. Patapoff, an h-index of 33, ranking #734,106 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Thomas W. Patapoff. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.